Higher inflation: more bad news for India
India’s economy (EPI, quote) took another turn for the worse this week when data released yesterday indicated a rise in consumer prices, bucking a trend of decreasing inflation.
Tag Archives: INFY
The secret behind the top Indian ETF
U.S. investors often stereotype the Indian economy as a cluster of gigantic technology outsourcing companies. But those who bought into the ETFs that most closely conform to that stereotype would have been left lagging not only the real Indian stock market but Wall Street as well.
Can India climb out from the downgrade?
Ratings agency Standard and Poor’s has cut India’s credit outlook to negative over multiple structural concerns plaguing India’s economy.
Could Infosys really be deeply undervalued?
The heaviest weighted stock in India has plunged nearly 16% since its earnings spooked global traders on Friday. Despite the carnage, reaction from analysts and ETF investors has been muted — revealing that the selling may have gone more than a little too far.
Trading the Globe: emerging technology
With headlines screaming that emerging markets need to spend $1.2 trillion on information technology just this year, the high-tech story starts to look global. We talk about the opportunities in today’s Trading the Globe.
Caution – one of the BRICs looks much more expensive than the rest
A note of caution for traders who have tried to get exposure to emerging markets via the BRIC countries of Brazil, India, Russia and China. Indian ETFs have run up ahead of their earnings and look like less of a bargain relative to their counterparts.
GlaxoSmithKline hands digital strategy to Infosys
Infosys Ltd (INFY, quote) announced a new partnership today with GlaxoSmithKline (GSK, quote) to optimize digital channels across its global consumer healthcare and pharmaceuticals business lines. The partnership in association with Fabric Worldwide will simplify and improve how GSK engages with consumers and healthcare professionals.